Comparing Owlet (OWLT) & Its Peers

Owlet (NYSE:OWLT) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Owlet to similar businesses based on the strength of its risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Owlet and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Owlet Competitors	-305.24%	-170.58%	-22.05%

Insider and Institutional Ownership

72.6% of Owlet shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Owlet and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1	1	3	0	2.40
Owlet Competitors	4279	10550	18327	829	2.46

Owlet currently has a consensus price target of $15.00, indicating a potential upside of 261.01%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.23%. Given Owlet’s higher possible upside, equities analysts clearly believe Owlet is more favorable than its competitors.

Valuation & Earnings

This table compares Owlet and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Owlet	$105.70 million	-$39.68 million	-5.54
Owlet Competitors	$1.88 billion	$138.79 million	10.35

Owlet’s competitors have higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Owlet has a beta of 2.17, indicating that its stock price is 117% more volatile than the S&P 500. Comparatively, Owlet’s competitors have a beta of 2.56, indicating that their average stock price is 156% more volatile than the S&P 500.

Summary

Owlet competitors beat Owlet on 7 of the 13 factors compared.

About Owlet

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.